A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
PLoS Negl Trop Dis
; 16(1): e0010089, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34990453
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Clinical Trials, Phase III as Topic
/
Drug Development
/
Lassa Fever
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
PLoS Negl Trop Dis
Journal subject:
MEDICINA TROPICAL
Year:
2022
Type:
Article
Affiliation country:
Nigeria